Alamar Biosciences is a leading proteomics company that specializes in advanced biomarker detection technologies. The company’s flagship NULISA platform enables researchers to detect a wide range of protein biomarkers with unparalleled sensitivity and accuracy. Their innovative solutions support early disease detection and personalized medicine, empowering scientists to unlock the full potential of the human proteome.
Founded: 2020
YULING LUO, PHD Founder, Chairman & CEO |
TOD WHITE, JD CFO/CBO |
STEVE CHEN, PHD Founder, COO |
XIAO-JUN MA, PHD CTO |
YIYUAN YIN, PHD Founder, VP of Technology |